EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SARS‐CoV‐2 infection among psoriasis patients in Germany: Data from the German registries PsoBest and CoronaBest

María José Valencia López, Anna Meineke, Brigitte Stephan iD, Stephan Jeff Rustenbach, Anne Kis iD, Diamant Thaçi, Ulrich Mrowietz, Kristian Reich, Petra Staubach-Renz, Ralph von Kiedrowski, Henriette Bogena, Matthias Augustin iD

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024

DOI: 10.1111/ddg.15433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024. Verfasst von María José Valencia López und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Hauptthemen laut MEDLINE: COVID-19, Psoriasis, Registries, SARS-CoV-2. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited data exist on the characteristics of SARS‐CoV‐2 infections in German patients with psoriasis or psoriasis arthritis (PsA). This study analyses COVID‐19 prevalence and severity of symptoms in these patients. Patients and Methods Participants of the German registries PsoBest and CoronaBest were surveyed in February 2022. Descriptive analyses were conducted.

Results

4,818 patients were included in the analysis, mean age of 56.4 years. Positive SARS‐CoV‐2 tests were reported by 737 (15.3%) patients. The most frequently reported acute symptoms were fatigue (67.3%), cough (58.8%), and headache (58.3%). Longer‐lasting symptoms after COVID‐19 were reported by 231 of 737 patients after the acute phase. For most patients (92.9%), systemic treatment for their psoriasis or PsA was not modified during the pandemic. Patients positively tested for SARS‐CoV‐2 were younger on average and had more often changes in the therapy of psoriasis than negatively tested patients (8.5% vs. 5.4%).

Conclusions

In this cohort of patients with psoriasis or PsA undergoing systemic treatment, SARS‐CoV‐2 infections were common but less frequent than in the general German population. No risk signals for more severe COVID‐19 or increased infection rates were observed in the patients. In addition, systemic treatments remained largely unchanged, so that no risks can be attributed to these therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PsoriasisRegistriesSARS-CoV-2HumansGermanyMiddle AgedMaleFemalePrevalenceAdultAgedArthritis, PsoriaticSeverity of Illness Index

Stichwörter der Autor:innen

COVID‐19CoronaBestPsoBestSARS‐CoV‐2psoriasisregistry

Autor:innen und Institutionen

  • Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
  • Psoriasis Center Kiel, Department of Dermatology, Venereology and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Department of Dermatology and Allergy, University Medical Center Mainz, Mainz, Germany.
  • Dermatological Practice Selters, Selters, Germany.

ORCID-Profile: Brigitte Stephan, Anne Kis, Matthias Augustin

Zitieren

APA

López, M. J. V., Meineke, A., Stephan, B., Rustenbach, S. J., Kis, A., Thaçi, D., Mrowietz, U., Reich, K., Staubach-Renz, P., von Kiedrowski, R., Bogena, H., & Augustin, M. (2024). SARS‐CoV‐2 infection among psoriasis patients in Germany: Data from the German registries PsoBest and CoronaBest. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15433

Vancouver

López MJV, Meineke A, Stephan B, Rustenbach SJ, Kis A, Thaçi D, et al. SARS‐CoV‐2 infection among psoriasis patients in Germany: Data from the German registries PsoBest and CoronaBest. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024. doi:10.1111/ddg.15433

BibTeX
@article{Lpez2024,
  author = {López, María José Valencia and Meineke, Anna and Stephan, Brigitte and Rustenbach, Stephan Jeff and Kis, Anne and Thaçi, Diamant and Mrowietz, Ulrich and Reich, Kristian and Staubach-Renz, Petra and von Kiedrowski, Ralph and Bogena, Henriette and Augustin, Matthias},
  title = {SARS‐CoV‐2 infection among psoriasis patients in Germany: Data from the German registries PsoBest and CoronaBest},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2024},
  doi = {10.1111/ddg.15433}
}
Kostenlos starten →